Funder

Innovate UK, GB: Transforming medicines manufacturing - Grand Challenges

Added date

12/10/2023

Closing date

15/11/2023

Call summary

The aim of this competition is to encourage the development and adoption of flexible, agile, scalable and sustainable technologies (FASST) across the supply chain for the development and manufacture of medicines. This Grand Challenge will establish a consortium to develop technologies and are expected to support enhanced manufacturing processes, with significant and measurable improvements to the speed and efficiency of pharmaceutical processes across the supply chain. This should lead to shorter development timelines, reduced time-to-market for new products and increase patient access to medicines. Your project must demonstrate collaborative R&D across supply chains. Amount note Your project must: have a grant funding request between £2 million and £4 million be led by a research and technology organisation (RTO), public sector organisation demonstrate co-investment of at least 100% of the total grant request last between 24 months and 60 months carry out all of its project work in the UK.

Scientific scope

Your project must focus on one or more of the following: lowering manufacturing costs reducing environmental impact of medicines manufacturing increasing patient access to products increasing yield increasing productivity increasing speed of data processing improving efficiency and remove bottlenecks reducing time to market reducing development time supporting process monitoring controls gathering and effectively utilising information from across the supply chain commitment to skills and talent development.

PI eligibility

Award amount max £4,000,000 Award amount min £2,000,000 Amount note Your project must: have a grant funding request between £2 million and £4 million be led by a research and technology organisation (RTO), public sector organisation demonstrate co-investment of at least 100% of the total grant request last between 24 months and 60 months carry out all of its project work in the UK intend to exploit the results from or in the UK start by 1 April 2024 end by 31 March 2026.